In Type II Diabetes Mellitus (TIIDM), cells exhibit resistance to insulin, constituting 90% of all diabetes cases, and are treated with either synthetic or natural medications to overcome this resistance [21,22]. This evidence concerns the gene INS and diabetes mellitus.